Bahrain’s Investcorp invests in Wuhan’s medical testing group, Kindstar

SourceGulf Business

Bahraini private equity firm Investcorp has invested in Kindstar Globalgene (“Kindstar”), the Chinese independent medical testing services group. The terms of the transaction, however, were not disclosed. Founded in 2003 and headquartered in Wuhan, Kindstar offers patients and physicians access to advanced specialty testing services across hematology, gynecology and pediatrics, infectious diseases, oncology and neurology.

It currently serves more than 3,000 hospitals in over 600 cities in China with advanced and nationally accredited clinical testing, scientific research and development laboratories. “Our focus on healthcare opportunities in China allowed us to identify Kindstar which has built impressive capabilities for improving the quality of healthcare through severe diseases related testing,” said Hazem Ben-Gacem, co-CEO of Investcorp. “We believe that Kindstar has significant growth potential driven by accelerating demand for precision medicine, underserved market and the more...